June 4, 2012- In the Wall Street Journal Op-Ed section– by Steven E. Greer
Early this year, I was briefly involved with one of the Affordable Care Act’s bureaucracies called Continue reading
June 4, 2012- In the Wall Street Journal Op-Ed section– by Steven E. Greer
Early this year, I was briefly involved with one of the Affordable Care Act’s bureaucracies called Continue reading
April 5, 2010 Opinion By Steven E. Greer, MD
The New York Times recently ran a front-page story raising concern about expanding the indication for statins to people with normal cholesterol levels, per the Crestor JUPITER trial. The article mentioned the new data in Lancet that suggest a diabetes risk from taking statins and compared that risk to the low absolute benefit from the statins. As has become common practice in the mainstream media, Dr. Steve Nissen was interviewed and quoted in the article. Dr. Nissen has been paid by AstraZeneca, maker of Crestor, and many other drug companies, but states that the funds were donated to charity and that there were no tax deduction benefits to him. Continue reading
Interviewed by Steven Greer, MD
Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation Continue reading
March 7, 2012 By Steven Greer, MD
We previously interviewed Special Agent Mark Trouville, the DEA agent in charge of tackling the rampant abuse of prescription opioid pain pills in Florida, and the “pain pill mill” system. Continue reading
February 22, 2012
Publisher: Grand Central Life & Style, Hachette Book Group
Review by Steven E. Greer, MD
What do all of these extremely athletic and strong professional athletes have in common? Heavyweight Continue reading
January 25, 2012 By Steven Greer, MD
I have worn contact lenses for more than twenty years without any problems. But recently, Continue reading
Update: June 11, 2012
The FDA briefing documents for the June 13 advisory committee to review the PARTNER- Continue reading
December 29, 2010
Many medical devices cause a far greater clinical impact than pharmaceutical therapies such Continue reading
By Steven Greer, MD
The CardioMEMS’ heart failure pressure measurement system will be evaluated by an FDA Continue reading
May 13, 2011- The Healthcare Channel hosted, in conjunction with Mark Schoenebaum of ISI, a tour of the Continue reading
February 16, 2011- by Steven Greer, MD
In Part 1 of our interview with Margaret Hamburg, MD, The Commissioner of the FDA, she discusses Continue reading
December 15, 2015
Dr. Paul Richardson of Harvard’s Dana-Farber Cancer Institute reviews the recent Lancet article Continue reading
November 23, 2010- Interviewed by Steven Greer, MD
Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients Continue reading
November 23, 2010- Interviewed by Steven Greer MD
Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients Continue reading
The CREST trial, published earlier this year, was the latest large-scale, randomized, controlled Continue reading
August 30, 2010- Produced and interviewed by Steven Greer, MD
A group from Harvard published a paper in The NEJM that showed early initiation of palliative Continue reading
August 2, 2010- Interviewed by Steven Greer, MD
As continuous flow pump LVAD devices are being implanted for longer periods of time in destination Continue reading
February 23, 2010– By Steven E. Greer, MD
Many in the cardiology community are a bit confused as to why Dr. Steven Nissen resorted Continue reading
December 9, 2009- Interviewed by Steven Greer, MD
The consensus among government budget forecasters such as the CBO is that the current growth Continue reading